Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × guadecitabine × Clear all

NCT01696032 2024-08-27

SGI-110

Phase 2 Completed

120 enrolled 22 charts

Ovarian Neoplasms

NCT02901899 2024-02-20

Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Completed

45 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms